Arindam Nandi is a Visiting Fellow based in Naperville, Illinois, USA.
Dr. Nandi’s research at the One Health Trust focuses on the value of vaccines, including their long-term health, cognitive, and schooling benefits, and reductions in antimicrobial resistance in low- and middle-income countries. He is currently working on a disease modeling project estimating the health and economic benefits of the pneumococcal, rotavirus, and HiB vaccines in the Indian context, and another project evaluating the impact of COVID-19 on children’s vaccination outcomes. Dr. Nandi is also involved in the world’s largest randomized trial study of the impact of a physical activity-based development program on the health and well-being of 20,000 Indian adolescents. In the recent past, he has jointly led the largest ever field study of the cost of delivering routine vaccination in seven Indian states. A list of his publications is available on his personal website: https://sites.google.com/site/arindamnandi/home.
Previously, Dr. Nandi worked as an associate at The Population Council. He received his PhD in Economics from the University of California, Riverside.
His research interests include health economics, public health, and demography.